May. 8 at 5:47 AM
$SINT No snoop, Kipke literally said otherwise. He’s the managing member of Medtech. Not a potential investor an pre-IPO investor recently returned. Yes Medtech likely cost basis harvested until it reinvested in Sintx but it’s back.
“Medtech Ceramics holds (a) 370,384 shares of common stock, (b) prefunded warrants to purchase 129,170 shares of common stock, (c) 760,881 warrants to purchase 760,881 shares of common stock, and (d) 507,254 shares of common stock underlying previously owned warrants.